Atlas Trials

Safety and Efficacy Study of Peginterferon Lambda-1a vs. Peginterferon Alfa-2a, Plus Ribavirin in Subjects With Genotype 1 Hepatitis C

Clinical trial NCT01754974 · COMPLETED

Trial details

NCT number
NCT01754974
Sponsor
Bristol-Myers Squibb
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Hepatitis C Virus (HCV)
Start date
2013-03-01
Primary completion
2014-09-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.